Search all medical codes

Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen rep

CPT4 code

Name of the Procedure:

Pathogen-Specific Nucleic Acid (DNA or RNA) Testing for Respiratory Tract Infections via Qualitative RT-PCR

Summary

This procedure involves testing a sample from your nose and throat to detect the presence of specific bacteria and viruses that cause respiratory infections. The test uses a powerful technology called qualitative RT-PCR to identify pathogens, including the virus responsible for COVID-19.

Purpose

The purpose of this test is to accurately identify the specific pathogen causing a respiratory tract infection. By pinpointing the exact cause, healthcare providers can tailor the most effective treatment plan. The test aims to diagnose conditions like COVID-19, flu, and other bacterial or viral infections.

Indications

This test is recommended for patients experiencing symptoms of respiratory infections such as:

  • Fever
  • Cough
  • Sore throat
  • Difficulty breathing
  • Fatigue
  • Body aches It is also appropriate for individuals who have been exposed to infectious respiratory pathogens.

Preparation

  • No special preparation is needed, but it’s advised to avoid nasal sprays or rinses prior to the test.
  • Inform your healthcare provider of any medications you are taking.

Procedure Description

  1. You will be seated comfortably while the healthcare provider explains the process.
  2. A sterile swab is gently inserted into one of your nostrils and moved towards the back of the throat to collect a sample.
  3. The collected sample is stored in a special container and sent to a laboratory.
  4. In the lab, RT-PCR technology is used to detect the genetic material of up to 22 different pathogens, including SARS-CoV-2.

Tools used:

  • Sterile nasopharyngeal swab
  • Collection container
  • RT-PCR machine and reagents

No anesthesia or sedation is needed.

Duration

The swabbing process takes about 1-2 minutes. Lab results are typically available within 24-48 hours.

Setting

The procedure is performed in a variety of settings including hospitals, outpatient clinics, and drive-through testing centers.

Personnel

  • Healthcare Provider (e.g., nurse or technician)
  • Laboratory Technologist

Risks and Complications

  • Minor discomfort or gagging during swab insertion
  • Rare cases of nosebleeds or minor irritation
  • Extremely rare risk of infection at the swab site

Benefits

  • Accurate and quick identification of the respiratory infection’s cause
  • Helps initiate timely and appropriate treatment
  • Reduces the risk of complications from undiagnosed infections

Recovery

  • No special post-procedure care is required.
  • You can resume normal activities immediately after the test.
  • Follow-up instructions depend on the test results.

Alternatives

  • Rapid antigen tests: Quicker but less accurate
  • Antibody tests: Less effective for diagnosing active infections
  • Clinical diagnosis based on symptoms alone: Less reliable

Patient Experience

You may feel slight discomfort or a tickling sensation during the swab collection. Most people tolerate the procedure well. After the test, you can expect minimal to no side effects, and pain management is typically not necessary.

Medical Policies and Guidelines for Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen rep

Related policies from health plans

Similar Codes